4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow AZD2014: new trials by email Literature Review of AZD2014 trials Research Report on AZD2014
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas AZD2014 - Neurofibromatosis 2, Meningioma | Phase 2 | Completed | Massachusetts General Hospital | 18 | 2016-08-31 | 2022-06-13 |
| National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer AZD4547, Vistusertib, Palbociclib - Non-Small Cell Lung Cancer, Carcinoma, Squamous Cell | Phase 2 | Completed | University of Birmingham | 423 | 2015-05-13 | 2026-04-28 |
| SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients AZD2014, AZD4547, AZD5363 - Non-small Cell Lung Cancer Metastatic | Phase 2 | Completed | UNICANCER | 999 | 2014-04-23 | 2024-01-10 |
| A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer AZD2014, Everolimus, Fulvestrant - Estrogen Receptor Positive Breast Cancer | Phase 2 | Completed | Queen Mary University of London | 333 | 2014-01-16 | 2024-12-02 |
Adenocarcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Lung Neoplasms (1) · Meningioma (1) · Neurofibromatosis 2 (1)
Massachusetts General Hospital (1) · Queen Mary University of London (1) · UNICANCER (1) · University of Birmingham (1)
France (2) · United Kingdom (2) · Georgia (1) · Germany (1) · Hungary (1) · Portugal (1) · Romania (1) · South Korea (1) · Spain (1) · United States (1)
Gary W Middleton (1) · Peter Schmid, Prof (1) · Scott Plotkin, MD, PhD (1)
PMID 26410619, PMID 31465093, PMID 32669708, PMID 40069402
2014 (1)